Institute of Neuroimmunology of the Slovak Academy of Sciences

Recent papers from Institute of Neuroimmunology of the Slovak Academy of Sciences

1. Size exclusion chromatography as a characterization tool for quality control of marine biopharmaceutical keyhole limpet hemocyaninActa Pharmaceutica · 2026
2. Remibrutinib versus teriflunomide in relapsing multiple sclerosis (REMODEL-1 and REMODEL-2): two randomised, phase 3 trialsThe Lancet · 2026
3. Linking protein misfolding and heat stress: a common role for the kynurenine pathwayMetabolic Brain Disease · 2026
4. Risk of Degenerative Spine Disease, Interventional Spine Procedures and Spine Surgery in Patients with Multiple SclerosisAmerican Journal of Physical Medicine & Rehabilitation · 2026
5. Multiple sclerosis and housing insecurity or forcible displacement: A scoping reviewMultiple Sclerosis Journal · 2026
6. Treatment of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): acute attacks, relapse prevention, and symptomatic careFrontiers in Neurology · 2026
7. EBV reactivation priming of the peripheral immune system in multiple sclerosis relapseNature Medicine · 2026
8. Developing a novel chimeric antimicrobial peptide for the treatment of central nervous system bacterial infectionsScientific Reports · 2026
9. Plasma neurofilament light chain in type 2 diabetes: Associations with diabetic peripheral neuropathy, age, and renal function in a pilot cross-sectional studyPLoS ONE · 2026
10. Protocol for project FIERCE: A randomized controlled trial to evaluate a positive emotion-focused meditation intervention for physicians with elevated stressPLoS ONE · 2026
11. Oral microbiota and serum metabolomics features in newly diagnosed anti-AchR antibody-positive myasthenia gravis patientsFrontiers in Immunology · 2026
12. Artery tertiary lymphoid organs encode a pathogenic high-affinity autoantibody−autoantigen pair in atherosclerosisNature Cardiovascular Research · 2026
13. A Truncated Serpin D1 Variant Regulates Adseverin-Dependent Actin Severing and Is Required for OsteoclastogenesisCells · 2026
14. Intracellular complement factor H protects neurons during CNS inflammationNature · 2026
15. Diagnostic value of the kappa free light chain index in multiple sclerosis under the 2024 CSF positivity criterion: a multicentre study in oligoclonal band-negative patientsFrontiers in Immunology · 2026
16. Efgartigimod-alfa therapy in acetylcholine receptor antibody myasthenia gravis: Romanian experienceFrontiers in Neurology · 2026
17. Treatment of multiple sclerosis with peptide-coupled red blood cells induces antigen-specific T regulatory cellsProceedings of the National Academy of Sciences · 2026
18. Clinical decision-making in older adults with multiple sclerosis: A National Delphi survey of Israeli MS specialistsJournal of the Neurological Sciences · 2026
19. Practical Guidance on Initiating and Switching Targeted Immunotherapies in Generalised Myasthenia Gravis: A German–Austrian Expert Opinion PaperEuropean Journal of Neurology · 2026
20. Rethinking Senescence Hallmarks in the Brain: Lessons From Peripheral Tissues and Challenges in Defining Neuronal SenescenceAging Cell · 2026